Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 0 | 994,000 | 1,437,000 | 1,164,000 | 1,247,000 |
| Cost of Goods | N/A | 707,000 | 787,000 | 681,000 | 757,000 |
| Gross Profit | N/A | 287,000 | 650,000 | 483,000 | 490,000 |
| Operating Expenses | 3,629 | 526,000 | 592,000 | 665,000 | 539,000 |
| Operating Income | -3,629 | -239,000 | 58,000 | -182,000 | -49,000 |
| Interest Expense | 0 | 129,000 | 161,000 | 159,000 | 167,000 |
| Other Income | -2,242 | -7,000 | -31,000 | 29,000 | 499,000 |
| Pre-tax Income | -5,871 | -375,000 | -134,000 | -312,000 | 283,000 |
| Income Tax | N/A | -280,000 | -1,000 | -16,000 | -313,000 |
| Net Income Continuous | -5,871 | -95,000 | -133,000 | -296,000 | 596,000 |
| Minority Interests | N/A | -2,000 | -1,000 | N/A | -1,000 |
| Net Income | $-5,871 | $-93,000 | $-132,000 | $-296,000 | $597,000 |
| EPS Basic Total Ops | -2.36 | -0.78 | -0.89 | -1.96 | 4.00 |
| EPS Basic Continuous Ops | -2.36 | -0.78 | -0.86 | -1.92 | 4.03 |
| EPS Diluted Total Ops | -2.36 | -0.36 | -0.89 | -1.96 | 3.57 |
| EPS Diluted Continuous Ops | -2.36 | -0.34 | -0.86 | -1.92 | 3.57 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.01 | -0.51 | -0.83 | -0.03 |
| EBITDA(a) | $-3,629 | $-40,000 | $258,000 | $31,000 | $162,000 |